Abstract
Clearance of cryptococcal polysaccharide (CP) from tissues and body fluids of nonimmune mice was studied. Mice were injected intravenously one time only with one mg of purified CP, and serum, urine and tissues were obtained from each animal at various intervals for a period of 84 days. Tissue extracts, serum and urine were tested for CP content by enzyme-linked immunosorbent assay (ELISA) and latex agglutination. High concentrations of CP were detected by both assays one-half hour after injection in blood (serum), liver, spleen, kidney and lung (extracts). The duration of ELISA detectable CP was longest (70 days) in liver and spleen and shortest (14 days) in lung extract. By 14 days after injection, concentration of CP in the blood fell below that found in the liver and spleen. CP remained detectable (titers 32–64) after all other extracts became negative. These results indicate that CP is stored in tissues (binding mechanism and site unknown), and that the liver and spleen possess greater storage capacity than other tissues. Antibody (IgM) to CP appeared in low titer on the 14th day and thereafter.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Avrameas, S., 1969. Coupling of enzymes to proteins with glutaraldehyde: use of the conjugate for the detection of antigens and antibodies. Immunochemistry. 6: 43–52.
Bennett, J. E. & Hasenclever, H. F., 1965. Cryptococcus neoformans polysaccharide: studies of serologic properties and role in infection. J. Immunol. 94: 916–920.
Bennett, J. E., Hasenclever, H. F. & Tynes, B. S., 1964. Detection of cryptococcal polysaccharide in serum of spinal fluid: value in diagnosis and prognosis. Trans. Ass. Am. Physns. 77: 145–150.
Bloomfield, N., Gordon, M. A. & Elmendorf Jr., D. F., 1963. Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc. Soc. Exp. Biol. Med. 114: 64–67.
Blumer, S. O. & Kaufman, L., 1977. Characterization of immunoglobulin classes of human antibodies to Cryptococcus neoformans. Mycopathol. 61: 55–60.
Bulmer, G. S. & Sans, M. D., 1968. Cryptococcus neoformans. III. Inhibition of phagocytosis. J. Bacteriol. 95: 5–8.
Kozel, T. R. & Cazin Jr., J., 1974. Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans. Mycopath. et Mycologia appl. 54: 21–30.
Kozel, T. R., Gulley, W. F. & Cazin Jr., J., 1977. Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect. Immun. 18: 701–707.
Kozel, T. R. & Mastroianni, R. P., 1976. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect. Immun. 14: 62–67.
Murphy, J. W. & Cozad, G. C., 1972. Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect. Immun. 5: 896–901.
Scott, E. N., Muchmore, H. G. & Felton, F. G., 1980. Development of an enzyme immunoassay for cryptococcal antibody. Mycopathol. 70: 55–59.
Scott, E. N., Muchmore, H. G. & Felton, F. G., 1980. Comparison of enzyme immunoassay and latex agglutination methods for detection of Cryptococcus neoformans antigen. Am. J. Clin. Pathol. 73: 790–794.
Tacker, J. R., Farhi, F. & Bulmer, G. S., 1972. Intracellular fate of Cryptococcus neoformans. Infect. Immun. 6: 162–167.
Walter, J. E. & Jones, R. D., 1968. Serodiagnosis of clinical cryptococcosis. Am. Rev. Resp. Dis. 97: 275–282.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muchmore, H.G., Scott, E.N., Felton, F.G. et al. Cryptococcal capsular polysaccharide clearance in nonimmune mice. Mycopathologia 78, 41–45 (1982). https://doi.org/10.1007/BF00436580
Issue Date:
DOI: https://doi.org/10.1007/BF00436580